相关实验视频
Updated: Jul 1, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
信号淋巴细胞激活分子家族受体作为固体瘤中潜在的免疫治疗标
Metin Gunes1, Steven T Rosen1,2, Idit Shachar3
1Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope, Los Angeles, CA, United States.
Frontiers in immunology
|March 13, 2024
概括
信号淋巴细胞激活分子家族 (SLAMF) 受体是瘤微环境中的关键. 向SLAMF可能会改善免疫疗法反应和固体瘤患者的存活率.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 癌症免疫疗法改善了一些固体瘤患者的生存率,但反应率各不相同.
- 瘤微环境显著影响免疫治疗的疗效.
- 信号淋巴细胞激活分子家族 (SLAMF) 受体是免疫细胞蛋白质,在癌症中越来越多地被研究.
研究的目的:
- 审查SLAMF受体在固体瘤和免疫细胞中的表达.
- 分析SLAMF受体表达与患者结果之间的关联.
- 探索在癌症免疫治疗中准SLAMF受体的治疗潜力.
主要方法:
- 对实体瘤中SLAMF受体表达研究的文献综述.
- 分析现有数据,将SLAMF表达与患者生存率和治疗反应相关联.
- 综合目前关于SLAMF向治疗的研究.
主要成果:
- SLAMF受体表达在瘤细胞和瘤透免疫细胞上.
- 在各种固体瘤中,SLAMF表达模式与患者的结果相关.
- 准SLAMF受体显示出增强抗瘤免疫力的前景.
结论:
- SLAMF受体代表了克服免疫疗法耐药性的潜在治疗标.
- 调节SLAMF信号可以改善固体瘤患者的临床结果.
- 对SLAMF向策略的进一步研究是有必要的,以加强癌症免疫疗法.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autocrine Signaling
48.0K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.0K

